seed
Stage
2017
Founded
1
Investors
About
MJN Neuroserveis develops and commercializes MJN-SERAS, a wearable medical device that uses artificial intelligence to detect the risk of epileptic seizures in real-time. The device provides alerts to patients and caregivers, aiming to improve safety and quality of life for individuals with epilepsy.
Explore MJN Neuroserveis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.